Jana Samarin
Impact in
-
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
-
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Ubiquitin and proteasome pathways 4
- Connective Tissue Growth Factor Research 4
- RNA modifications and cancer 2
- Protein Kinase Regulation and GTPase Signaling 2
- Co-authors
- Peter SchirmacherKai BreuhahnMichaela BissingerMargarete Goppelt‐StruebeVolker EhemannNorbert GretzIwona CichaMona Malz
- Journals
- Hepatology (3 papers)Molecular Cancer Research (1 paper)Journal of Hepatology (1 paper)Journal of Biological Chemistry (1 paper)International Journal of Cancer (1 paper)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Jana Samarin
12 papers receiving 340 citations
Peers
Comparison fields: 5 of 53
- Cancer Research 116
- Hepatology 31
- Molecular Biology 249
- Oncology 68
- Cell Biology 38
Countries citing papers authored by Jana Samarin
This map shows the geographic impact of Jana Samarin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jana Samarin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jana Samarin more than expected).
Fields of papers citing papers by Jana Samarin
This network shows the impact of papers produced by Jana Samarin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jana Samarin. The network helps show where Jana Samarin may publish in the future.
Co-authors
The 25 scholars most cited alongside Jana Samarin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 55 | |
| 2 | 2014 | 37 | |
| 3 | 2014 | 1 | |
| 4 | 2012 | 23 | |
| 5 | 2011 | 40 | |
| 6 | 2011 | 22 | |
| 7 | 2010 | 6 | |
| 8 | 2009 | 17 | |
| 9 | 2009 | 16 | |
| 10 | 2009 | 33 | |
| 11 | 2008 | 90 | |
| 12 | [Insulin-like growth factor (IGF)-signalling pathway components are potential therapeutic targets in the treatment of human hepatocellular carcinoma]. | 2007 | 2 |
About Jana Samarin
Jana Samarin is a scholar working on Cell Biology, Molecular Biology, Cancer Research, Complementary and alternative medicine and Endocrinology, Diabetes and Metabolism, having authored 12 papers that have together received 342 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (4 papers), Connective Tissue Growth Factor Research (4 papers), Cancer-related Molecular Pathways (3 papers), RNA modifications and cancer (2 papers), Protein Kinase Regulation and GTPase Signaling (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Biomarkers in Disease Mechanisms (2 papers) and Growth Hormone and Insulin-like Growth Factors (2 papers). The work is most often cited by research in Cancer Research (116 citations), Hepatology (31 citations), Molecular Biology (249 citations), Oncology (68 citations) and Cell Biology (38 citations). Jana Samarin has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Peter Schirmacher, Kai Breuhahn, Michaela Bissinger, Margarete Goppelt‐Struebe, Volker Ehemann, Norbert Gretz, Iwona Cicha, Mona Malz, Xiaolei Yu and Eduard Ryschich. Their work appears in journals such as Hepatology, Molecular Cancer Research, Journal of Hepatology, Journal of Biological Chemistry and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.